AptarGroup Says Unidose Is The Delivery System Approved With Neffy (Epinephrine Nasal Spray), The First And Only Needle-Free Treatment Approved By FDA For Emergency Treatment Of Patients With Allergic Reactions (Type I)
Portfolio Pulse from Benzinga Newsdesk
AptarGroup's Unidose delivery system has been approved by the FDA for use with Neffy, the first and only needle-free epinephrine nasal spray for emergency treatment of allergic reactions.
August 15, 2024 | 9:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AptarGroup's Unidose delivery system has received FDA approval for use with Neffy, the first needle-free epinephrine nasal spray for emergency allergic reactions.
The FDA approval of AptarGroup's Unidose delivery system for Neffy is a significant milestone, likely to boost the company's market position and revenue potential in the medical device sector.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100